SEC Filings - Lyell Immunopharma, Inc.

Filing date	Form	Description	View
Apr 22, 2024	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001140361-24-021008.pdf 0001140361-24-021008.rtf 0001140361-24-021008.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jun 14, 2021	CORRESP	CORRESP	0001193125-21-190090.pdf 0001193125-21-190090.rtf 0001193125-21-190090.xls View HTML
Jun 07, 2021	CORRESP	CORRESP	0001193125-21-183938.pdf 0001193125-21-183938.rtf View HTML
Jun 14, 2021	CORRESP	CORRESP	0001193125-21-190080.pdf 0001193125-21-190080.rtf 0001193125-21-190080.xls View HTML
Jun 01, 2021	CORRESP	CORRESP	0001193125-21-178234.pdf 0001193125-21-178234.rtf 0001193125-21-178234.xls View HTML
May 28, 2021	CORRESP	CORRESP	0001193125-21-177261.pdf 0001193125-21-177261.rtf 0001193125-21-177261.xls View HTML
May 01, 2024	CORRESP	CORRESP	0001193125-24-127548.pdf 0001193125-24-127548.rtf 0001193125-24-127548.xls View HTML
Apr 28, 2023	ARS	An annual report to security holders	0001140361-23-021541.pdf 0001140361-23-021541.rtf View HTML
Apr 22, 2024	ARS	An annual report to security holders	0001140361-24-021014.pdf 0001140361-24-021014.rtf View HTML
Oct 01, 2021	8-K/A	Amendment to a previously filed 8-K	0001193125-21-288697.pdf 0001193125-21-288697.rtf 0001193125-21-288697.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.